4.6 Article

Lentivirus-mediated shRNA interference targeting STAT3 inhibits human pancreatic cancer cell invasion

Journal

WORLD JOURNAL OF GASTROENTEROLOGY
Volume 15, Issue 30, Pages 3757-3766

Publisher

BAISHIDENG PUBLISHING GROUP INC
DOI: 10.3748/wjg.15.3757

Keywords

Signal transducer and activator of transcription 3; RNA interference; Lentivirus vector; Pancreatic cancer cells; Invasion

Funding

  1. Affiliated First People's Hospital
  2. Shanghai Jiao Tong University
  3. Board of Education Fund for Scientific Research of Shanghai, China [06BE067]

Ask authors/readers for more resources

AIM: To investigate RNA interference targeting signal transducer and activator of transcription-3 (STAT3) on invasion of human pancreatic cancer cells. METHODS: We constructed three plasmids of RNA interference targeting the STAT3 gene. After LV (lentivirus)-STAT3siRNA (STAT3 small interfering RNA) the vector was transfected into the human pancreatic cell line, SW1990 and cell proliferation was measured by the MTT assay. Flow cytometry was used to assess cell cycle. Vascular endothelial growth factor (VEGF) and matrix metalloproteinase-2 (MMP-2) mRNA and protein expression were examined by quantitative PCR and western blotting, respectively. The invasion ability of SW1990 cells was determined by cell invasion assay. RESULTS: We successfully constructed the LV-STAT3siRNA lentivirus vector and proved that it can suppress expression of STAT3 gene in SW1990 cells. RNA interference of STAT3 by the LV-STAT3siRNA construct significantly inhibited the growth of SW1990 cells, in addition to significantly decreasing both VEGF and MMP-2 mRNA and protein expression. Moreover, suppression of STAT3 by LV-STAT3siRNA decreased the invasion ability of SW1990 cells. CONCLUSION: The STAT3 signaling pathway may provide a novel therapeutic target for the treatment of pancreatic cancer since it inhibits the invasion ability of pancreatic cancer cells. (C) 2009 The WJG Press and Baishideng. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available